Dr Eugene S Hrabarchuk, MD | |
165 State Hwy 23, Franklin, NJ 07416 | |
(973) 827-5255 | |
(973) 827-0026 |
Full Name | Dr Eugene S Hrabarchuk |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 165 State Hwy 23, Franklin, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396704938 | NPI | - | NPPES |
1872702 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | MA 41053 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Eugene S Hrabarchuk, MD 165 State Hwy 23, Franklin, NJ 07416 Ph: (973) 827-5255 | Dr Eugene S Hrabarchuk, MD 165 State Hwy 23, Franklin, NJ 07416 Ph: (973) 827-5255 |
News Archive
Two previously unrecognized genetic markers may predict whether breast cancer patients would benefit from chemotherapy followed by tamoxifen, according to preclinical research from Roswell Park Cancer Institute, in collaboration with the cooperative research group SWOG and St. Jude Children's Research Hospital. The results of this research will be presented at the American Association for Cancer Research Annual Meeting 2016, to be held April 16-20 in New Orleans.
A new implantable sensor device provides a less-invasive alternative for monitoring pressure within the skull (intracranial pressure, or ICP), suggests a pilot study in Operative Neurosurgery, a quarterly supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons.
Mitochondria are cell organelles located within animal and human cells. They produce energy for the organism, possess their own genetic material - mitochondrial DNA (mtDNA) - and are transmitted exclusively by the mother. Depending on their activity and tasks, different numbers of mitochondria are present in a cell - usually a few hundred to a thousand per body cell.
Each year approximately 1 in 1,000 pregnant women will experience peripartum cardiomyopathy, an uncommon form of often severe heart failure that occurs in the final month of pregnancy or up to five months following delivery. But the cause of peripartum cardiomyopathy has been largely unknown - until now.
› Verified 5 days ago